Amrita Krishnan, MD on the Best Myeloma Maintenance Approach After Transplant — IMW 2019 HealthTree Foundation for Multiple Myeloma 2:16 5 years ago 536 Далее Скачать
Amrita Krishnan, MD, regarding outcomes from the CASSIOPEIA trial presented at ASCO '19 OBRoncology 1:15 5 years ago 83 Далее Скачать
Amrita Krishnan M.D., on Treatment Options for Multiple Myeloma | #ASCO21 City of Hope 1:17 3 years ago 155 Далее Скачать
Dr. Amrita Krishnan: Virtual NBC4 Broadcast | City of Hope Orange County City of Hope Orange County 2:15 4 years ago 236 Далее Скачать
Amrita Krishnan, M.D., Discusses a New Class of Myeloma Therapies | #ASCO21 City of Hope 1:32 3 years ago 210 Далее Скачать
Amrita Krishnan, MD, tells us about the Phase 3 Dreamm-3 study presented at ASH 2019 OBRoncology 1:02 5 years ago 22 Далее Скачать
Hope Talks | Setting the standard for care: Todd Kennedy and Amrita Krishnan, M.D. City of Hope 4:23 3 years ago 379 Далее Скачать
Amrita Krishnan, MD, tells us about the outcomes of the ECOG trial in SMM OBRoncology 1:31 5 years ago 12 Далее Скачать
Myeloma: tackling high-risk disease VJHemOnc – Video Journal of Hematology & HemOnc 0:49 5 years ago 91 Далее Скачать
Dr. Krishnan on Key Aspects of the ELOQUENT Trials in Relapsed/Refractory Multiple Myeloma OncLive 1:16 5 years ago 87 Далее Скачать
MM: when is allogeneic transplant is the right answer? VJHemOnc – Video Journal of Hematology & HemOnc 1:55 5 years ago 50 Далее Скачать
First-in-human study of talquetamab: a GPRC5D-CD3 bispecific antibody for R/R MM VJHemOnc – Video Journal of Hematology & HemOnc 2:25 4 years ago 173 Далее Скачать
S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance OncologyTube 2:21 4 years ago 63 Далее Скачать
Mezagitamab: an anti-CD38 antibody for R/R MM VJHemOnc – Video Journal of Hematology & HemOnc 1:14 5 years ago 241 Далее Скачать
The efficacy of cevostamab in R/R multiple myeloma and the importance of bispecific antibodies VJHemOnc – Video Journal of Hematology & HemOnc 1:38 2 years ago 85 Далее Скачать
